Press release
Triptorelin Drug Market Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast - 2022 to 2028
The global triptorelin drug market is anticipated to grow at a CAGR of 4.2% during the forecast period (2022-2028). Prostate Cancer is dominating the highest market share as well as it is one of the most common cancers in American men. North America region holds the largest market share in the global triptorelin drug market owing to rising incidence of prostate cancer and salivary gland cancer and growing prevalence of central precocious puberty among the young patients below the age of eight and nine years. During the projection period, triptorelin pamoate is anticipated to grow at the highest rate. Debiopharm has developed three triptorelin pamoate sustained-release formulations (one, three, and six months).A full report of Triptorelin Drug Market is available at:https://orionmarketreports.com/triptorelin-drug-market/94944/
Triptorelin is a gonadotropin-releasing hormone agonist analogue, it is a peptide injection formulation that was originally developed to treat advanced metastatic prostate cancer. Treatment of uterine fibroids (a benign tumor of muscular tissues in the uterus), endometriosis prior to surgery, early-onset puberty, and female infertility are among the various indications that have emerged since then (in vitro fertilization).
In order to maintain their market position, triptorelin product manufacturers are updating their product portfolios by employing inorganic expansion tactics. For instance, in June 2019, Debiopharm and Ipsen renewed their Decapeptyl agreement, extending and strengthening their strategic cooperation for the development, production, and distribution of Decapeptyl across Europe, as well as some Asian and African regions, until 2034.
Triptorelin drug market growth is being fueled by increased R&D for a variety of therapeutic purposes. The market is growing due to increased research & development in triptorelin for usage in various therapeutic indications by private producers and research institutions. Several clinical trials are now underway to see if triptorelin may be used to treat breast cancer and the Human Immunodeficiency Virus (HIV). Triptorelin's widespread use in prostate cancer, salivary gland cancer, and central precious puberty is also projected to drive market expansion throughout the forecasted period. Furthermore, triptorelin's efficacy and safety in the reduction of gonadotropin secretion in prostate cancer and precocious puberty are expanding its market penetration.
Some major players in the market include Arbor Pharmaceuticals, LLC, Debiopharm International SA, Ipsen Pharma, Xbrane Biopharma, among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in January 2019, Debiopharm Group and Allergan announced an agreement to begin a transition process for Trelstar (Triptorelin pamoate), with the goal of new licensees taking over Trelstar commercialization in the US and Canada and Allergan's partnership with Debiopharm being terminated for strategic reasons.
Market Coverage
The market number available for - 2021-2028
Base year- 2021
Forecast period- 2022-2028
Segment Covered-
By Type
By Application
By Distribution Channel
Regions Covered-
North America
Europe
Asia-Pacific
Rest of the World
Competitive Landscape- Arbor Pharmaceuticals, LLC, Debiopharm International SA, Ipsen Pharma, Xbrane Biopharma, among others.
Key questions addressed by the report
What is the market growth rate?
Which segment and region dominate the market in the base year?
Which segment and region will project the fastest growth in the market?
How has COVID-19 impacted the market?
Deviation from the pre-COVID-19 forecast
Most affected region and segment
Who is the leader in the market?
How players are addressing challenges to sustain growth?
Where is the investment opportunity?
Global Triptorelin Drug Market Report by Segment
By Type
Triptorelin Pamoate
Triptorelin Acetate
Triptorelin Embonate
By Application
Prostate Cancer
Radical Prostatectomy
Salivary Gland Cancer
Endometriosis
Central Precocious Puberty
By Distribution Channel
Online Pharmacy
Offline Pharmacy
Media Contact:
Company Name: Orion Market Reports
Contact Person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +91 780-304-0404
About Us:
Orion Market Reports (OMR) endeavors to provide exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Triptorelin Drug Market Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast - 2022 to 2028 here
News-ID: 2592360 • Views: …
More Releases from Orion Market Reports
Module Power Supply Market to see Huge Growth by 2031
The Module Power Supply Market is experiencing substantial growth, fueled by increasing demand for efficient, compact, and reliable power solutions across a wide range of industries. These power supplies, which convert electrical power to a suitable form for specific applications, are essential in sectors like telecommunications, automotive, medical devices, and consumer electronics. With technological advancements and rising energy efficiency needs, the market is expected to continue expanding, driven by innovations…
Plasma Spray Guns Market to see Rapid Growth by 2031
The Plasma Spray Guns Market is witnessing significant growth, driven by the rising demand for surface coating and thermal spray applications across industries such as aerospace, automotive, manufacturing, and electronics. Plasma spray guns are widely used for depositing coatings on substrates to enhance their properties, including wear resistance, corrosion resistance, and thermal protection. As industries continue to focus on improving product performance and durability, the plasma spray gun market is…
Plasma Surface Treatment Machine Market Will Generate Record Revenue by 2031
The Plasma Surface Treatment Machine Market is witnessing significant growth as industries increasingly adopt plasma surface treatment technology for enhancing the properties of materials. Plasma surface treatment machines are used to modify the surface characteristics of materials like metals, plastics, and ceramics, offering improvements in adhesion, corrosion resistance, and wear resistance. As the demand for advanced surface treatments rises across automotive, electronics, packaging, and manufacturing sectors, the market for plasma…
Plasma Torch Market Value Projected to Expand by 2031
The Plasma Torch Market is experiencing rapid growth, driven by the increasing demand for high-precision cutting and welding technologies in industries such as manufacturing, automotive, aerospace, and construction. Plasma torches are essential tools in thermal cutting applications, offering fast and accurate cuts on various materials, including metals, plastics, and composites. With advancements in plasma cutting technology and the growing need for energy-efficient solutions, the market for plasma torches continues to…
More Releases for Triptorelin
Triptorelin Market Size, Share, Trends, and Forecast: 2024-2031
"Triptorelin Market 2024,"
The objectives outlined in the report are multifaceted and aimed at offering a comprehensive understanding of the Triptorelin market dynamics. These objectives encompass a meticulous analysis and forecast of the market's dimensions, encompassing both its value and volume aspects. Additionally, the report seeks to discern and delineate the market shares held by major segments within the Triptorelin industry, providing stakeholders with a nuanced perspective on market dynamics.
Furthermore, the report…
Triptorelin Market, by Product Type (Triptorelin pamoate, Triptorelin acetate, a …
The triptorelin market was valued at US$ 171.7 Mn in 2022 and is expected to exhibit a CAGR of 5.5% over the forecast period (2023-2033).
Among the numerous medications for achieving medical castration, gonadotropin-releasing hormone (GnRH) agonists have a better safety and effectiveness profile than oestrogens and anti-androgens. Slow-release GnRH agonist formulations also give patients flexibility, raise quality of life, and eventually lower costs. Prostate cancer typically advances with rising testosterone…
Global Triptorelin Acetate Market Production and Consumption Reports 2018
This report studies the global Triptorelin Acetate market status and forecast, categorizes the global Triptorelin Acetate market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa.
Triptorelin Acetate is a peptide formulation for injection that was initially developed and continues to be used mainly in the treatment of advanced metastatic…
Triptorelin Market Trends, and Forecast to 2026
Gonadotropin-releasing hormone (GnRH) agonists have greater safety and efficacy profile than estrogens and anti-androgens among various therapies of achieving medical castration. Furthermore, slow-release formulations of GnRH agonists offer patients flexibility, improves quality of life, and eventually reduce cost. Most of the times, prostate cancer progresses with increasing testosterone hormone. Moreover, the production of testosterone can be stopped by surgically removing the testicles or thorough medication therapy. Triptorelin is GnRH agonists…
Triptorelin Market to surpass US$ 670 million by 2026
Gonadotropin-releasing hormone (GnRH) agonists have greater safety and efficacy profile than estrogens and anti-androgens among various therapies of achieving medical castration. Furthermore, slow-release formulations of GnRH agonists offer patients flexibility, improves quality of life, and eventually reduce cost. Most of the times, prostate cancer progresses with increasing testosterone hormone. Moreover, the production of testosterone can be stopped by surgically removing the testicles or thorough medication therapy. Triptorelin is GnRH agonists…
Global Triptorelin Acetate Market 2021- Analysis and Trends
“Global Triptorelin Acetate Market by Manufacturers, Regions, Type and Application, Forecast to 2021” Purchase This Report by calling ResearchnReports.com at +1-888-631-6977.
The Global Triptorelin Acetate Market 2016 Research Report is a professional in-depth study report and indeed a valuable source of guidance and direction for companies and individuals interested in the market.
There has been an increasing demand for Global Triptorelin Acetate Market, so several market analysts have dedicated time and…
